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Despite the inverse association between skin colour and efficiency of cutaneous vitamin D
synthesis, in addition to the widely accepted racial disparity in vitamin D status, populations
of ethnic minority are understudied in terms of setting target serum 25-hydroxyvitamin D
concentrations and corresponding dietary requirements for vitamin D. In minority groups,
prevention of vitamin D deficiency on a population basis is challenging due to the lack of
clarity surrounding the metabolism and transport of vitamin D. Authoritative agencies
have been unable to define pregnancy-specific dietary recommendations for vitamin D,
owing to an absence of sufficient evidence to confirm whether nutritional requirements
for vitamin D are altered during pregnancy. While the question of setting race- and preg-
nancy-specific dietary reference values for vitamin D has not been addressed to date,
endemic vitamin D deficiency has been reported among gravidae worldwide, specifically
among ethnic minorities and white women resident at high latitude. In light of the
increased risk of nutritional rickets among infants of ethnic minority, coupled with
growing evidence for potential non-skeletal roles of vitamin D in perinatal health, deter-
mination of the dietary vitamin D requirement that will prevent deficiency during preg-
nancy is a research priority. However, systematic approaches to establishing dietary
requirements are limited by the quality of the available evidence and the under-represen-
tation of minority groups in clinical research. This review considers the evidence for racial
differences in vitamin D status and response to vitamin D supplementation, with particu-
lar application to pregnancy-specific requirements among ethnic minorities resident at
high latitudes.
Ethnicity: Minority groups: Pregnancy: Vitamin D requirements
Owing to the inverse association between skin colour and
the efficiency of cutaneous vitamin D synthesis(1), popu-
lations of ethnic minority are considered an at-risk group
for vitamin D deficiency, whereby the observed racial
disparity in vitamin D status has created a widely held
impression that dietary vitamin D requirements are
higher compared with native white populations.
However, this concept is based upon a paucity of experi-
mental evidence and individuals of ethnic minority
remain understudied in terms of setting target serum
25-hydroxyvitamin D (25(OH)D) concentrations and
corresponding dietary requirements for vitamin D(2,3).
In pregnancy, the absence of sufficient evidence from
appropriately designed, randomised controlled trials lim-
its the understanding of a probable increased metabolic
demand for vitamin D throughout gestation, regardless
of ethnicity. As such, authoritative agencies to date
have been unable to define race-specific or pregnancy-
specific dietary recommendations for vitamin D, due to
a lack of experimental evidence to confirm whether nutri-
tional requirements for vitamin D differ by ethnicity or
during pregnancy(4). By necessity, dietary reference
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values (DRV) for vitamin D in non-pregnant adults have
therefore been extended to pregnancy and lactation,
assuming equivalent recommendations for all racial and
ethnic groups(4–7).
Endemic vitamin D deficiency has been reported
among gravidae worldwide, particularly among ethnic
minorities(8), and nutritional rickets secondary to vitamin
D deficiency is most prevalent among neonates born to
women with dark or black skin(9). The most recent
national report from Ireland and the UK has estimated
the overall annual incidence rate of hypocalcaemic sei-
zures due to vitamin D deficiency as 3·49 per million chil-
dren aged 0–15 years. When stratified by ethnicity, the
incidence rate rises from 0·46 per million white children
to as high as 20·70 and 26·04 per million children
among those of black and South Asian origin, respec-
tively(10). Similarly in Australia, 98 % of 398 children iden-
tified with rickets had dark skin and 75 % were refugees,
highlighting minority populations as a particularly at-risk
group(11). As neonatal circulating 25(OH)D concentra-
tions are dependent on maternal vitamin D status, at min-
imum, vitamin D deficiency during pregnancy should be
prevented to ensure adequate development of the fetal
skeleton(9,12). While neonatal requirements are unknown,
avoidance of umbilical cord 25(OH)D concentrations
below 25–30 nmol/l is prudent(13,14) and consistent with
the prevention of nutritional rickets(9). Considering cord
serum 25(OH)D concentrations are typically 60–80 % of
maternal values collected at delivery(15,16), prevention of
maternal vitamin D deficiency at the lower threshold of
25–30 nmol/l will not ensure fetal protection at the same
threshold. Evidence now suggests that aiming to prevent
both maternal and neonatal deficiency requires achieve-
ment of a maternal cut-off of at least 50 nmol/l(17,18).
In terms of public health, DRV are useful to evaluate
nutrient intakes and prevent nutritional deficiencies at a
population level(19). Determination of pregnancy-specific
dietary vitamin D recommendations could therefore fun-
damentally help to tackle the high prevalence of global
vitamin D deficiency in this life-stage group(8). The lack
of both race- and pregnancy-specific dietary recommen-
dations places pregnant women of ethnic minority
among the most vulnerable and underinvestigated popu-
lation groups with regards to vitamin D. This review
explores the evidence for racial differences in response
to vitamin D supplementation, with particular applica-
tion to pregnancy-specific requirements among ethnic
minorities resident at high latitude.
Current dietary requirements for vitamin D during
pregnancy
The relationship between circulating serum 25(OH)D and
markers of bone health has been well established and
provides the most robust evidence upon which DRV can
be set(4). Nonetheless, accumulating evidence of a role
for vitamin D in non-skeletal health outcomes, including
immune function, cancer prevention and cardiovascular
health, complicates the establishment of deficiency thresh-
olds. In pregnancy specifically, evidence for an association
of low vitamin D status with adverse perinatal outcomes is
growing(13), which has implications for pregnancy-specific
requirements for vitamin D. It is plausible that a greater
vitamin D intake may be required during pregnancy to
improve perinatal outcomes than that necessary to sup-
port skeletal growth and development of the fetus.
Though evidence to date has been insufficient to justify
setting target serum 25(OH)D concentrations based on
non-skeletal health outcomes, it is likely that future studies
will merit consideration of pregnancy-specific 25(OH)D
thresholds. In the interim, it is reasonable to apply equiva-
lent thresholds of vitamin D deficiency and sufficiency to
both pregnant and non-pregnant adults.
Notwithstanding the controversies regarding 25(OH)D
thresholds and the knowledge gaps surrounding the
putative extra-skeletal role of vitamin D, several authori-
tative agencies have defined DRV for vitamin D in recent
years, all of which have been determined based on a pre-
dominantly white population. Using a risk assessment
framework, the Institute of Medicine established DRV
for vitamin D by way of systematic evidence-based reviews
to answer a priori defined questions regarding vitamin D
and health, resulting in a landmark report with global
application(4). In line with the Institute of Medicine, this
approach has since been adopted by other agencies, as it
allows for transparent evaluation of the data and alleviates
decision-making(19). As shown in Table 1, variations in the
data analysed led to the establishment of more conserva-
tive recommendations among health authorities in
Northern Europe(5) and the UK(6). Despite adopting a
similar risk assessment approach to other agencies, and
being the only expert body to include pregnancy-related
outcomes, the latest scientific opinion published by the
European Food Safety Authority(7) cites insufficient data
to define average or individual dietary requirements for
vitamin D. We have recently expressed our regret for the
decision by the European Food Safety Authority to advise
Table 1. Summary of the current dietary recommendations for vitamin D in pregnant women
Agency Countries
25(OH)D threshold (nmol/l) Vitamin D intake (μg/d)
Deficiency Population average Individual target EAR RI AI
IOM (2011)(4) USA/Canada <30 40 ≥50 10 15
NORDEN (2012)(5) Nordic <30 – ≥50 7·5 10
SACN (2016)(6) UK <25 – ≥25 – 10
EFSA (2016)(7) EU – – ≥50 – – 15
25(OH)D, 25-hydroxyvitamin D; EAR, estimated average requirement; RI, recommended (individual) intake; AI, adequate intake; IOM, Institute of Medicine;
NORDEN, Nordic Council of Ministers; SACN, Scientific Advisory Committee on Nutrition; EFSA, European Food Safety Authority. Table adapted from Kiely et al.(13).
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an adequate intake in lieu of an estimated average require-
ment (EAR intake level of a nutrient that meets the needs
of 50 % of the population) or RDA (intake level of a nutri-
ent sufficient to meet the needs of almost all (97·5 %)
healthy people in a population) value. In terms of public
policy and health practice, an adequate intake offers little
clinical utility, specifically during pregnancy where imple-
mentation of a risk management approach to prevent vita-
min D deficiency is likely required. An additional
consideration is that application of an EAR value to preg-
nancymay not be appropriate; a more cautionary approach
would be to set an RDA target for pregnant women. Seeing
as this population is under medical supervision, application
of an RDA is justifiable. Furthermore, we stress that DRV
estimates for pregnancy should be established with the aim
of achieving the 25(OH)D target that will ensure protection
against both maternal and neonatal deficiency. Should
requirements be determined based onmaintainingmaternal
status >25–30 nmol/l, neonatal deficiency will not be pre-
vented. As an alternative, application of an RDA value to
maintain circulating 25(OH)D concentrations ≥50 nmol/l
in 97·5 % of gravidae would likely guarantee prevention of
neonatal vitamin D deficiency while simultaneously
improving maternal vitamin D status(17,18).
Ethnic variations in vitamin D status
According to the recent systematic review by Saraf et al.(8),
the global prevalence of 25(OH)D concentrations <50
nmol/l is 54 % among pregnant women and 75 % among
newborns, denoting a worldwide public health concern.
Almost one in five pregnant women and one in three new-
borns had concentrations <25 nmol/l, the widely acknowl-
edged threshold at which there is increased risk of
developing rickets and osteomalacia(4). With the exception
of fish and fish liver oils, few foods are naturally rich in vita-
min D, meaning the predominant source of vitamin D is
sunlight(20). In cases of limited sun exposure, careful dietary
planning is required to ensure adequate vitaminD intake for
deficiency prevention. In the Western world, deficiency is
thereforemost often observed amonggravidae andneonates
from ethnic minorities(8,21), whereas white populations are
most at risk when resident at high latitude(8). As such, case
reports of rickets are found predominantly in immigrant
children and those with darker skin pigmentation(11,22–25).
Risk is highest among breastfed children without vitamin
D supplementation, whose mothers had low vitamin D sta-
tus during pregnancy and lactation due to inadequate diet-
ary intakes and insufficient cutaneous vitamin D
production because of darker skin and veiled clothing(9).
Ethnic disparities in vitamin D status within the UK
were brought to light in the latter half of the 20th cen-
tury, whereby a series of comparative prospective and
cross-sectional studies described a high frequency of
deficiency among pregnant Asian and African minor-
ities(26–28). In addition, an accumulation of case reports
documented an increase in the number of children diag-
nosed with vitamin D-dependent rickets, the majority of
whom were born to mothers from outside of the
UK(23,29–31). Despite efforts from health authorities to
increase the awareness of the importance of dietary vita-
min D intake among immigrant populations(6), more
recent data suggest that the observed racial disparity in
25(OH)D status throughout pregnancy has not changed,
with women of ethnic minority consistently presenting
with lower vitamin D status during pregnancy than
their native white counterparts(21,32–34).
Outside of pregnancy, lower 25(OH)D concentrations
are consistently reported among racial and ethnic minor-
ities, regardless of sex and age(35–37). Of note is the
decline in circulating 25(OH)D among immigrants that
often follows relocation to areas of more Northern lati-
tude, provided the vitamin D content of the diet is not
improved(38). Conversely, dietary transition from a trad-
itional vitamin D-rich diet (e.g. native Inuit) to a more
Western style diet parallels a reduction in vitamin D
status(39). Recent data from the European Commission-
funded collaborative ODIN project (Food-based solu-
tions for Optimal vitamin D Nutrition and health
throughout the lifecycle; http://www.odin-vitd.eu)(3)
revealed that the annual prevalence of vitamin D defic-
iency (25(OH)D < 30 nmol/l) among non-white sub-
groups in the UK, Norway and Finland is 3- to 71-fold
higher compared with white populations. In the UK,
deficiency is greatest among the Asian ethnic group
(59·6 %, n 52), compared with the black (35·7 %, n 28)
and white (19·6 %, n 1359) population, and South
Asian immigrants in Norway show a remarkably higher
prevalence of deficiency (64·8 %, n 176) than that observed
in native white adults (1·3 %, n 866). Similarly, results from
the Finnish Maamu study stress that inter-ethnic variations
in vitamin D status are not limited to native and immigrant
populations but are also evident within non-white ethnic
groups residing in the same country. Based on standardised
25(OH)D data, 4·5, 28·0 and 50·4 % of white Russian-
speaking (n 446), Somali (n 364) and Kurdish (n 50) adults,
respectively, were classified as vitamin D deficient(3). In the
USA, year-round 25(OH)D concentrations <30 and 50
nmol/l are more apparent in non-Hispanic black (24 and
62 %, respectively) than Hispanic (6·4 and 36·0 %, respect-
ively) populations, and least evident in those of white eth-
nicity (2·3 and 13·0 %, respectively)(40), while non-white
ethnicity was recognised as a primary predictor of reduced
25(OH)D status among adult Canadians(41) and
Australian adolescents(42) (mean concentrations not spe-
cified). In their audit of over 850 refugees, Wishart
et al.(43) described a high prevalence of low vitamin D sta-
tus (54 % <50 nmol/l) among this population in New
Zealand. Moreover, women of child-bearing age were
identified as a particular at-risk group (78 % <50 nmol/l),
alluding to the circle of low vitamin D status among
mother–infant pairs, which leads to increased risk of vita-
min D-deficiency rickets in immigrant children(43).
Ethnic considerations for 25-hydroxyvitamin D
thresholds
Skeletal health and calcium metabolism
In their dietary reference intake report, the Institute of
Medicine highlighted uncertainty around the effect of
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genetic variation among racial and ethnic groups, which
may have implications for nutrient requirements.
Polymorphisms in the vitamin D-binding protein (VDBP),
vitamin D receptor and both 25- and 24-hydroxylases
have been identified, and the Institute of Medicine has
stressed the need to elucidate to what extent such poly-
morphisms will affect the epigenetic regulation of vitamin
D during pregnancy and subsequent developmental out-
comes in the offspring(4). Despite the recognised knowledge
gaps, the possibility that vitamin D requirements will differ
based on race or ethnicity is both inclusive and exclusive of
genetic variation in vitamin D metabolism. Several other
factors should therefore be considered in addition to genetic
determinants. The limited experimental evidence led to the
establishment of mutual DRV estimates for vitamin D
that are inclusive of all population groups. However,
whether it is appropriate to assign DRV to all ethnic groups
using data extrapolated from dose–response curves in pre-
dominantly white populations is questionable. First,
25(OH)D will likely have a greater impact on calcium
metabolism and skeletal health at different thresholds
depending on the populations studied. The inverse relation-
shipbetween theparathyroidhormone (PTH)and25(OH)D
has been well established; low circulating 25(OH)D concen-
trations result in increased PTH expression, which triggers
the subsequent production of 1,25-dihydroxyvitamin D,
the active metabolite. The negative feedback loops involved
in the calciummetabolic system therefore function to main-
tain calcium homeostasis(44). The fact that black men and
women have lower 25(OH)D concentrations but increased
bone mineral density (BMD), coupled with increased
1,25-dihydroxyvitamin D, hence suggests a skeletal resist-
ance to the effect of PTH in this population(45).
Racial differences inbonemass(46–48) andcalciummetab-
olism(48,49) are apparent froma young age. Across a defined
range of calcium intakes, black adolescent females were
found to have higher rates of net calcium absorption and
retention, and lower urinary calcium excretion than white
females of the same age(48), which is consistentwithfindings
from single-dose studies(49,50). Similarly, black men were
shown to have the greatest levels of BMDand bonemineral
content at various skeletal sites when compared with
Hispanic and white males(51). Data from the National
Health and Nutrition Examination Survey (2003–2004
cycle and 2005–2006 cycle) showed reduceddietary calcium
intake, higher PTH and lower 25(OH)D concentrations
among blacks. Differences in mean BMD, however, were
not found between Mexican and white Americans (2003–
2004 cycle only)(52). Within-group comparisons confirmed
the inverse relationship of dietary calcium intake and/or cir-
culating 25(OH)D with PTH is retained across all ethnic
groups, albeit only in white and Mexican Americans did a
decrease in BMD parallel a decrease in calcium intake
and/or 25(OH)D status(52). More recently, the higher levels
of BMDwith lower 25(OH)D in blacks were verified in the
multi-ethnic study of atherosclerosis, which also showed
that the low 25(OH)D/low BMD relationship observed
for both white and Asian adults was not present in
Hispanic participants(53).
Cosman et al.(54) provided direct evidence for lower
rates of bone resorption in response to PTH infusion in
black compared with white women. Higher PTH concen-
trations have been reported among African American
women compared with Caucasians, both in the preg-
nant(55) and non-pregnant(56) state, a trend only partially
explained by the higher BMI and lower 25(OH)D status
often seen among African Americans(56). PTH levels
have been shown to both rise and plateau at a lower
25(OH)D concentration in black adults(52,57,58), which
in turn questions the use of mutual 25(OH)D thresholds
to define deficiency in all racial groups. While the inverse
PTH/25(OH)D relationship was maintained both above
and below the 50 nmol/l threshold in white and
Mexican Americans participating in the National
Health and Nutrition Examination Survey, PTH levels
reached a plateau in blacks at a 25(OH)D concentration
below this cut-off, suggesting maximum suppression of
PTH may occur at lower 25(OH)D concentrations in
blacks than other ethnic groups. Thus, the evaluation
of vitamin D sufficiency among black populations is hin-
dered by a literature as yet insufficient to justify the
establishment of population-specific deficiency thresholds
based on race or ethnicity.
Application of standardised thresholds is further compli-
cated in pregnancy, whereby the inverse PTH/25(OH)D
relationship is slightly weakened(55,59), likely resulting from
increased placental production of 1,25-dihydroxyvitamin
Dand/or the pregnancy-specific independent increase in cal-
ciumabsorption(55). The actions of PTH-related protein that
regulate mineral metabolism, independent of PTH, chal-
lenge our understanding of the PTH–vitamin D–calcium
axis in pregnancy and fetal metabolism(59). Hence, the
threshold relationship between 25(OH)D and PTH during
pregnancy is somewhat controversial, as the low PTH/
25(OH)D correlation hampers the estimation of the
25(OH)D threshold above which PTH begins to plateau(55).
Vitamin D binding protein and free 25-hydroxyvitamin D
The presence of superior skeletal health in tandem with a
lower vitamin D status among black men and women has
been termed a paradox(60). However, because nutritional
rickets is observed among black children in the presence
of severe vitamin D deficiency(11,24), the association
between low 25(OH)D status and poor bone health can-
not be race-specific. Powe et al.(37) were the first to
describe African American women as genetically predis-
posed to lower levels of the VDBP. Theoretically, free
25(OH)D concentrations are increased at lower levels
of VDBP, resulting in a greater proportion of 25(OH)D
available to cells. Through indirect measures, Powe
et al.(37) found the levels of free 25(OH)D did not differ
by race, despite a lower total 25(OH)D status among
African American women. Notwithstanding criti-
cism(61,62) of the methodology used by Powe et al.(37) to
analyse VDBP and thus calculate free 25(OH)D concen-
trations, these results were later confirmed by Aloia
et al.(63) using a direct method for the quantification of
free 25(OH)D, but contrast with the more recent data
from Alzaman et al.(64) and Nielson et al.(62). Both stud-
ies(62,64) argue that monoclonal antibody assays do not
show equal affinity for all VDBP genotypes and that racial
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differences in VDBP concentrations are not observed when
measured using polyclonal assay methods. Monoclonal
antibody assays will thus always underestimate VDBP
concentrations in blacks, resulting in higher free circulating
25(OH)D.
While the concept of racial similarities in free 25(OH)D
concentrations offers some insight towards the paradox
of lower vitamin D status but improved bone health
among black populations, this hypothesis is largely
unproven and future research in this area is warranted.
Regarding pregnancy specifically, whether free 25(OH)D
concentrations remain similar among black and white
pregnant women is disputed(65,66), and the clinical contri-
bution of free 25(OH)D to perinatal health is unknown.
Nonetheless, as free 25(OH)D correlates with total
25(OH)D(62), and given the unresolved debate regarding
ethnic differences in VDBP, the lower total 25(OH)D
status in ethnic minorities(36,38,42) remains a concern, par-
ticularly during pregnancy when neonatal 25(OH)D avail-
ability must be considered. To paraphrase Quraishi
et al.(67), we advocate that until the physiological signifi-
cance of bioavailable 25(OH)D is fully understood and
the contributions of vitamin D-related gene polymorph-
isms to human health have been established, a reasonable
objective is to aim for the achievement of targeted inter-
nationally applied 25(OH)D thresholds to prevent defic-
iency among the general population, including during
pregnancy.
Ethnic differences in the response to vitamin D
supplementation
Children
Comparative studies investigating the response to vita-
min D supplementation between populations are limited,
despite uncertainty that the metabolism and transport of
consumed vitamin D is identical across all ethnic groups.
Delineating the racial disparities in response to supple-
mentation is necessary to ensure the efficacy and safety
of supplemental vitamin D, specifically for pregnant
women and their neonates(8). Even within the available
literature, however, incomplete subject characterisation
is often a limiting factor when extrapolating the findings.
In a comparative study of black and white children, the
effect of supplementation with 25 µg/d varied by race;
an increase in 25(OH)D concentrations following 2
months of supplementation was significant only for
black children, which may be a result of their lower
mean baseline 25(OH)D concentrations. At the end of
the 6-month supplementation period, the change in
25(OH)D concentrations was similar for both groups,
and the lower mean 25(OH)D and higher PTH concen-
trations among black children persisted from baseline
to completion of the intervention(68). Most recently, a
winter-based randomised trial in Sweden (55–63°N)
reported variations in the dietary requirement for vita-
min D according to the skin colour among children
aged 5–7 years. Based on the achievement of a 25(OH)
D concentration of 30 nmol/l, an RDA of 6 and 14 µg
was estimated for fair- and dark-skinned children,
respectively, whereas 20 and 28 µg was estimated at the
50 nmol/l threshold, respectively. Baseline vitamin D sta-
tus was shown to predict the response to vitamin D sup-
plementation; despite a greater magnitude of increase
among dark-skinned children, total serum 25(OH)D con-
centrations remained higher in fair-skinned children at
the end of the trial(69).
Adults
Following a 1-year intervention period at various vita-
min D doses from 10 to 60 µg/d, supplementation with
10 µg/d achieved a 25(OH)D concentration of 50 nmol/l
in 50 % of young non-pregnant white and African
American women, suggesting the EAR for vitamin D
does not differ by race(70). In terms of an RDA, a
value of 10 µg/d was estimated among white women,
whereas 30 µg/d was required for 97·5 % of African
American women to achieve 50 nmol/l. While a linear
response to the dosing regimen was observed for both
ethnic groups, the difference in the dose–response curves
is worth noting. As 25(OH)D concentrations were lower
in black than white women prior to supplementation, the
absolute increase in 25(OH)D was greater in blacks and
final concentrations were similar for both ethnicities at
the higher doses(70). In contrast, no interaction effect by
race was observed among older adults. Gallagher et al.
showed that the achieved 25(OH)D concentrations in
response to supplementation did not differ between
white and African American women, for which a mutual
RDA of 20 µg/d was suggested(71,72). The combined ana-
lysis of two large vitamin D intervention trials of black
and white prediabetic and diabetic adults in the USA
suggests the response to supplementation is similar for
both populations and that supplementation will increase
free 25(OH)D concentrations in direct proportion to
changes in total 25(OH)D, independent of race(64).
Taken collectively, the metabolism and transport of vita-
min D therefore seems equivalent in blacks and
whites(64,72). Hence, the higher magnitude of change in
25(OH)D concentrations observed in blacks compared
with whites following equimolar doses of vitamin D
may be a corollary of lower 25(OH)D levels in this popu-
lation prior to the intervention, whereby a wide inter-
individual variation in the dose–response is likely to
increase requirements at the individual level (i.e. at the
97·5th percentile)(73). Therefore, it is plausible that, at a
given mean 25(OH)D concentration, vitamin D require-
ments do not differ by race, but that additional vitamin
D may be required among black populations to meet
the requirement at the 97·5th percentile (i.e. the RDA).
Moving beyond the comparative studies, results from
a large, four-arm (placebo and 25, 50 and 100 µg/d) ran-
domised trial in African American adults reported a
vitamin D intake of 41 µg/d was needed to reach the
RDA-associated 25(OH)D threshold of 50 nmol/l(74),
but this study has been criticised in terms of its design
and interpretation. Firstly, Brannon et al.(2) have dis-
puted the need for such high doses of vitamin D, stating
the aim should not be to achieve a population intake
equivalent to the RDA, as to do so would result in
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a shift in the population distribution of 25(OH)D to
values that exceed the upper limit where the risk of
hypercalcaemia increases sharply. Brannon et al. claim
that dose–response trials should focus on the estimations
of the EAR, for which dietary requirements refer to the
needs of the population rather than the individual(2).
However, unlike many nutrients, estimation of both an
EAR and RDA is possible through dose–response trials
with vitamin D, as 25(OH)D is a valid biomarker of
exposure and conditions of minimal UVB availability
are achieved at high latitude in winter. Therefore, report-
ing the vitamin D intake required to maintain 25(OH)D
concentrations across a range of thresholds, including the
dose needed to meet both the EAR and RDA values,
would be most beneficial in terms of establishing public
health policy. As discussed earlier, reporting of both indi-
vidual and population requirements would have particu-
lar application in pregnancy, where an RDA value may
be the prudent target. In response to the comments pro-
vided by Brannon et al.(2), the authors published supple-
mentary data corresponding to an intake level of 30 µg/d
to reach the EAR-associated threshold of 40 nmol/l in
97·5 % of the study population(75). The major drawback
of this study(2) is that the dose–response modelling used
in the DRV estimation does not consider background
dietary vitamin D intakes as the authors felt this was neg-
ligible at <5 µg/d. Hence, the intake values reported in
this study(75) can only be interpreted as the supplementa-
tion dose needed to achieve specific 25(OH)D thresholds,
in addition to that obtained from diet.
Further considerations
An additional concern underpinning ethnic-specific diet-
ary requirements for vitamin D is that DRV estimates are
based on the assumption that calcium intakes are
adequate, and that calcium requirements do not differ
by ethnic group. In reality, however, calcium intakes
tend to be lower in black adults(76–78), despite the afore-
mentioned increase in BMD compared with white popu-
lations. If dietary vitamin D requirements differ by
ethnicity, it is plausible that calcium requirements follow
a similar trend. Heaney(79) estimated that the calcium
requirements of African American women are up to
300 mg/d less than white women, likely due to a more
efficient calcium economy(60). Thus, the question as to
whether dietary vitamin D (and calcium) recommenda-
tions should differ by race is again complicated by the
fact that current DRV for vitamin D have been estab-
lished based on markers of bone health. While black
populations may require less calcium for skeletal health,
a similar or potentially greater dietary requirement for
vitamin D may co-exist for skeletal and non-skeletal
health benefits(80). Acknowledging the lack of evidence
to support safe long-term high vitamin D intakes(4), high-
dose vitamin D diet regimes should be avoided until clear
target 25(OH)D thresholds have been established.
Further to the uncertainty regarding the response to
supplementation, is the limited understanding of whether
the catabolism and storage of vitamin D is similar across
all ethnic groups. Should the half-life of 25(OH)D
vary by ethnicity, this would also have implications for
vitamin D requirements and would, to some extent,
contradict the clinical significance of the free hormone
hypothesis proposed by Powe et al.(37). Binding to the
VDBP facilitates avoidance of a rapid decline in vitamin
D status by stabilising the levels of circulating vitamin D
metabolites and modulating conversion to the active
metabolite, thereby prolonging the half-life of 25(OH)D.
When fed vitamin D replete diets, VDBP knock-out
mice have low levels of circulating 25(OH)D but do not
display the physiological symptoms of deficiency until
introduced to a vitamin D deplete diet, suggesting a con-
tinuous supply of vitamin D intake will offset the conse-
quences of deficiency in the absence of sufficient
VDBP(81). In populations that express genetic polymorph-
isms in the VDBP, including that commonly observed in
blacks, the associated low VDBP levels may predispose
to vitamin D deficiency, provided adequate dietary and/
or UV sources are not available(37). Considering the
widely acknowledged seasonal variation in vitamin D sta-
tus, such observations imply that populations with a high
prevalence of VDBP polymorphisms may be susceptible
to a more rapid winter-dependent decline in 25(OH)D
concentrations. In a comparative study of white and
South Asian men and women in the UK, Kift et al.(36)
suggested that South Asians would need to achieve a
higher 25(OH)D concentration than white populations
during the summer months in order to maintain suffi-
ciency throughout winter. Nonetheless, the lower vitamin
D intake and reduced efficacy of cutaneous vitamin D
production in pigmented skin among South Asians(1)
also contributes to the increased dependence on peak sum-
mer concentrations to maintain sufficiency throughout the
winter months and this is independent of any polymorph-
ism in VDBP. Thus, while genetic determinants of vitamin
D status may partially explain ethnic variations in defic-
iency prevalence, this area requires further detailed explor-
ation. In the interim, public health policy must consider
the modifiable ethnocultural risk factors of deficiency,
whereby supplement use may be the only feasible method
to ensure adequate 25(OH)D status in populations charac-
terised by low dietary vitamin D intakes and limited sun
exposure.
Challenges for research and policy
Research and recruitment
Following introduction of the 1993 National Institutes of
Health Revitalisation Act(82), considerable efforts have
been made to include ethnic diversity in funded research
within the USA. This, however, is seldom an easy task
and populations of ethnic minority remain under-
represented in clinical and health research(83,84). Across
Europe, the importance of integrating minority groups
in research is well known but strategic approaches to
recruitment and retention of ethnic minorities to clinical
or dietary intervention trials are rarely implemented.
Meaningful comparisons across ethnic groups are there-
fore hindered by small and unequal sample sizes, which
often lack statistical power, and the likelihood of
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self-selection bias limits extrapolation of the findings to
the wider population. Barriers to the implementation of
health research mirror barriers to the provision of health
care; mainly communication difficulties, religious or cul-
tural conservativeness and modesty, delay in seeking
clinical advice and poor attendance to scheduled
appointments(84,85). While a number of qualitative and
narrative reviews have provided guidance on how best
to engage minority populations in research(83,85–87), bar-
riers to recruitment will not be mutually exclusive for all
ethnic groups, research areas or study designs, and it is
likely that regionally tailored recruitment strategies are
required. With reference to vitamin D specifically, sub-
group analysis by ethnicity is preferable owing to the dis-
parities in vitamin D status and the possibility that ethnic
origin could modify the primary outcome (e.g. vitamin D
requirements). The literature depicts a lack of dose–
response trials with vitamin D among Hispanic and
Mexican Americans within the USA, and while the num-
ber of published studies in Asian subgroups continues to
grow, there is a compelling demand for a specifically
designed, culturally sensitive, randomised trial that will
assess the explicit needs of the South Asian population
who represent the largest minority group within the
UK(88).
Policy implementation
A higher skin pigmentation coupled with minimum skin
exposure to sunlight leads to an increased dependence on
food sources of vitamin D among minority popula-
tions(89–93). However, comparative studies highlight var-
iations in the vitamin D content of the diet between
ethnic groups, with total vitamin D intake typically low-
est among Asian populations(94,95). Both vitamin D sup-
plementation and fortification represent effective
strategies for the improvement of nutritional intake and
corresponding vitamin D status(96). In particular during
pregnancy, inclusion of supplemental vitamin D to the
antenatal routine could significantly improve vitamin D
status, provided women are compliant with supplement
use. Similar to dietary intake, antenatal supplement use
has been shown to vary by ethnicity, at least from an
Irish perspective, with prevalence highest among the
white population (52 %) and lowest among the Middle
Eastern and North African populations (17 %)(97).
Moreover, many commercially available vitamin D sup-
plements are not suitable for those following a vegan,
kosher or halal diet, meaning affordable supplements
are not readily accessible to the particular subgroups
that need them most. If not strategically executed, fortifi-
cation of food staples has the potential to neglect vulner-
able groups with dietary preferences and specific food
intolerances. In the USA, where fluid milk and
ready-to-eat breakfast cereals are the major contributors
to vitamin D intake, significant ethnic differences are
observed in the intake level from these foods on account
of the higher prevalence of lactose intolerance and
reduced milk consumption among African American
populations(78,94,95,98). Failure to address the specific
needs of minority populations will therefore result in an
unsuccessful national public health policy, which may
only magnify existent disparities in health inequalities.
Conclusions
While present data indicate a black–white disparity in the
25(OH)D threshold that should define vitamin D defic-
iency, at least in terms of bone health, data in Asian
and Hispanic populations are limited and contradicting,
and data in perinatal populations are almost entirely
unavailable. Considering the growing evidence in sup-
port of a non-skeletal role for vitamin D, assessing the
health outcomes at various 25(OH)D threshold levels
across ethnic groups should be made a priority in future
studies. Health authorities must now readdress vitamin
D requirements among both pregnant women and indivi-
duals of ethnic minority in order to overcome the global
inequities in vitamin D status and subsequent perinatal
outcomes. Understanding ethnic disparities in the metab-
olism and tissue-specific function of vitamin D is critical
to safely establish targeted public health campaigns, but
we stress that identifying ethnic and racial differences in
the association of vitamin D status with health outcomes
is independent to identifying the response to dietary
intake. In order to facilitate the establishment of race-
specific DRV, future studies must therefore follow a
two-step process: first to determine the appropriate
threshold for 25(OH)D across diverse populations, and
secondly to estimate the amount of vitamin D needed
to maintain this threshold across ethnic groups.
Dietary composition represents a modifiable factor for
the improvement of vitamin D status in at-risk ethnic
groups, provided relevant dietary advice and supplemen-
tation regimens are established. Public health campaigns
need to target ethnic groups specifically and move away
from the one-guideline-suits-all approach. Outreach
strategies must be culturally tailored and population-
focused, while avoiding marginalisation. Efforts should
be made to educate minority groups on the value of diet-
ary vitamin D, specifically in pregnancy and throughout
infancy. Finally, it is important to acknowledge that eth-
nic minorities represent a heterogeneous group in our
society, whose cultural values and norms vary widely.
Understanding the diverse sociocultural needs of ethnic
minorities is therefore central to the encouragement of
diversity in health research, and will be a crucial first
step to underpinning strategies to tackle the observed
high prevalence of vitamin D deficiency among pregnant
women and their neonates at high latitude.
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